Alkem Labs initiates forensic audit over alleged fund misappropriation by former employee
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Midcap 150 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alkem Laboratories' Audit Committee approved a forensic audit by Grant Thornton Bharat LLP to investigate alleged misappropriation of funds by a former employee. The audit will review electronically stored information and procurement transactions to identify irregularities, root cause, and recommend corrective measures. The company has not disclosed the financial impact yet.
Mixed - shows proactive governance but raises concerns about internal controls. Watch for audit findings and any estimated financial impact.